1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. 2 Chan JK,Brady MF,Penson RT,et al.Weekly vs.every-3-week paclitaxel and carboplatin for ovarian cancer[J].N Engl J Med,2016,374(8):738-748. 3 Drakes ML,Mehrotra S,Aldulescu M,et al.Stratification of ovarian tumor pathology by expression of programmed cell death-1(PD-1)and PD-ligand-1(PD-L1)in ovarian cancer[J].J Ovarian Res,2018,11(1):43. 4 Blank CU,Haining WN,Held W,et al.Defining 'T cell exhaustion'[J].Nat Rev Immunol,2019,19(11):665-674. 5 Normann MC,Türzer M,Diep LM,et al.Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer[J].J Gynecol Oncol,2019,30(4):e56. 6 Zhao HY,Gao Y,Miao JW,et al.Single-cell RNA-seq highlights a specific carcinoembryonic cluster in ovarian cancer[J].Cell Death Dis,2021,13,12(11):1082. 7 Guo JH,Han XY,Li J,et al.Single-cell transcriptomics in ovarian cancer identify a metastasis-associated cell cluster overexpressed RAB13[J].J Transl Med,2023,12,21(1):254. 8 Geistlinger L,Oh S,Ramo M,et al.Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma[J].Cancer Res,2020,80(20):4335-4345. 9 Beltra JC,Manne S,Abdel-Hakeem MS,et al.Developmental relationships of four Exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms[J].Immunity,2020,52:825-841. 10 Hellmann MD,Rizvi NA,Goldman JW,et al.Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer(CheckMate 012):results of an open-label,phase 1,multicohort study[J].Lancet Oncol,2017,18:31-41. 11 Park CG,Lee SY,Kandala G,et al.A novel gene product that couples tcr signaling to Fas(Cd95)expression in activation-induced cell death[J].Immunity,1996,4:583-591. 12 Fearon AE,Carter EP,Clayton NS,et al.PHLDA1 mediates drug resistance in receptor tyrosine kinase-driven Cancer[J].Cell Rep,2018,22(9):2469-2481. 13 Wang J,Yao N,Hu Y,et al.PHLDA1 promotes glioblastoma cell growth via sustaining the activation state of Ras[J].Cell Mol Life Sci,2022,79(10):520. 14 Joo JH,Liao G,Collins JB,et al.Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response[J].Cancer Res,2007,67:7929-7936. 15 Peng H,Wang JP,Song XH,et al.PHLDA1 suppresses TLR4-triggered proinflammatory cytokine production by interaction with tollip[J].Front Immunol,2022,13:731500. 16 Chen Y,Takikawa M,Tsutsumi S,et al.PHLDA1,another PHLDA family protein that inhibits Akt[J].Cancer Sci,2018,109(11):3532-3542. 17 Zhou X,Fang D,Liu H,et al.PMN-MDSCs accumulation induced by CXCL1 promotes CD8+ T cells exhaustion in gastric cancer[J].Cancer Lett,2022,532:215598. 18 Oberg H,Sipos B,Kalthoff H,et al.Regulation of T-cell death-associated gene 51(TDAG51)expression in human T-cells[J].Cell Death Differ,2004,11(6):674-684. 19 Nagai MA.Pleckstrin homology‐like domain,family A,member 1(PHLDA1)and cancer[J].Biomed Rep,2016,4(3):275-281. |